Department of Life Science, College of Biomedical & Health Science, Konkuk University, Chungju 380-701, Korea.
J Ginseng Res. 2011 Nov;35(4):487-96. doi: 10.5142/jgr.2011.35.4.487.
Good manufacturing practice (GMP)-based quality control is an integral component of the common technical document, a formal documentation process for applying a marketing authorization holder to those countries where ginseng is classified as a medicine. In addition, authentication of the physico-chemical properties of ginsenoside reference materials, and qualitative and quantitative batch analytical data based on validated analytical procedures are prerequisites for certifying GMP. Therefore, the aim of this study was to propose an authentication process for isolated ginsenosides Rb1 and Rg1 as reference materials (RM) and for these compounds to be designated as RMs for ginseng preparations throughout the world. Ginsenoside Rb1 and Rg1 were isolated by Diaion HP-20 adsorption chromatography, silica gel flash chromatography, recrystallization, and preparative HPLC. HPLC fractions corresponding to those two ginsenosides were recrystallized in appropriate solvents for the analysis of physico-chemical properties. Documentation of the isolated ginsenosides was made according to the method proposed by Gaedcke and Steinhoff. The ginsenosides were subjected to analyses of their general characteristics, identification, purity, content quantitation, and mass balance tests. The isolated ginsenosides were proven to be a single compound when analyzed by three different HPLC systems. Also, the water content was found to be 0.940% for Rb1 and 0.485% for Rg1, meaning that the net mass balance for ginsenoside Rb1 and Rg1 were 99.060% and 99.515%, respectively. From these results, we could assess and propose a full spectrum of physicochemical properties for the ginsenosides Rb1 and Rg1 as standard reference materials for GMP-based quality control.
基于良好生产规范 (GMP) 的质量控制是共同技术文件的一个组成部分,这是向那些将人参归类为药品的国家申请营销许可持有人的正式文件编制程序。此外,基于经过验证的分析程序对人参皂苷参考物质的物理化学性质进行认证,以及对批次分析数据进行定性和定量分析,是认证 GMP 的前提条件。因此,本研究旨在提出一种用于分离的人参皂苷 Rb1 和 Rg1 作为参考物质 (RM) 的认证过程,并将这些化合物指定为全球人参制剂的 RM。人参皂苷 Rb1 和 Rg1 通过 Diaion HP-20 吸附色谱、硅胶快速色谱、重结晶和制备 HPLC 分离。与这两种人参皂苷相对应的 HPLC 馏分在适当的溶剂中重结晶,用于分析物理化学性质。根据 Gaedcke 和 Steinhoff 提出的方法对分离的人参皂苷进行了记录。对人参皂苷进行了一般特征、鉴定、纯度、含量定量和质量平衡测试分析。当用三种不同的 HPLC 系统分析时,分离出的人参皂苷被证明是单一化合物。此外,Rb1 的水分含量为 0.940%,Rg1 的水分含量为 0.485%,这意味着人参皂苷 Rb1 和 Rg1 的净质量平衡分别为 99.060%和 99.515%。根据这些结果,我们可以评估并提出人参皂苷 Rb1 和 Rg1 的全面物理化学性质,作为基于 GMP 的质量控制的标准参考物质。